Opinion
Video
Richard Adler, MD, FACS, reviews a patient case and discusses the ongoing discussion on how to define and identify dry eye disease.
FDA accepts NDA from Aldeyra Therapeutics for reproxalap for dry eye
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
New canalicular gel shows promise for dry eye treatment
Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD
Intense pulsed light for treatment of dry eye disease
Prevalence of dry eye disease-related symptoms higher in South America